MANFRED REITER, PhD
Senior Vice President, Manufacturing
Dr. Reiter joined Vivaldi in 2017 as Senior Vice President, Manufacturing, with responsibility for process development and GMP manufacture of the company’s candidate vaccines. Dr. Reiter has more than 30 years of experience managing process development and manufacturing teams for the development of human vaccines and recombinant therapeutic proteins, including cell-based production with Vero and other platforms. He has substantial experience with technologies and processes utilized in pre-clinical, clinical, and commercial development of biologicals, including scale-up and technology transfer to CMOs. Previously, Dr. Reiter was Vice President of Process Development & Manufacturing at Hookipa Biotech AG, managing cell-based GMP cell-substrate production of viral and cancer vaccines at a US CMO. Prior to his position at Hookipa, Dr. Reiter was with Baxter Bioscience for 14 years, initially as Director, Upstream Process Development, and then as Senior Director, Process Development, Vaccines & Therapeutics, with responsibility for a team of 130 process scientists and engineers for process development, and clinical and commercial production of vaccines and therapeutic proteins. Earlier, Dr. Reiter was Manager, Microbiological & Cell Biological Process Development at Immuno AG. Dr. Reiter is an inventor on 25 vaccine and therapeutic protein patent families, with more than 700 international patent records. He received a Diplom Ingenie from the University of Natural Resources & Life Sciences, Vienna, and a PhD in Biotechnology from the Institute for Applied Microbiology, University of Natural Resources & Life Sciences, Vienna.